do-good way one reiter outperform
produc solid result rule sever consecut
quarters/year upsid come opinion midpoint ffo
guidanc rang reiter mtm leas trend --
posit foreshadow remaind year meanwhil estim
tick significantli larg tie highly-cash-flow-gener
develop project place servic quarter success
compani substanti role play biopharma industri also enabl
give back commun form project aid opioid epidem
estim slightli despit reiter guidanc effect
boost pt assum chang methodolog
solid quarter come
ffo adjust beat estim although
midpoint full year guidanc reiter rang tighten
bottom top end hurdl re-leas activ
cash basi previou guidanc actual result
tell us two thing littl conservat built
outlook out-performance despit high hurdl suggest
continu upsid know ultim translat higher
ffo guidanc rang road build block growth appear
move bottom/left top/right increas
ffo estim respect feel
could recur theme year
span singl quarter estim increas see
figur last quarter function roughli
increas valu higher noi run-rat develop come line
leas valu estim ever-
expand develop pipelin past month consensu estim
increas new estim current averag
expect market trend closer number analyst re-jigg model
import buy stock singularli reli growth like
one-two punch cash-flow growth later -- uniqu characterist
platform
rise ytd trade all-tim high stock arguabl
expens plu polit rhetor headlin risk surround drug price
medicare-for-al chief risk stori access equiti market
abil sell mani asset near cap rate evidenc partial sale
binney cambridg either go offens
hunker even balanc sheet combin two approach without
give earn growth process debt/ebitda target end
current given currenc see scenario
hit even lower number continu drive growth intern extern
sourc acknowledg risk see momentum make valuat
secondari consider time
nikko secur america inc nikko america affili seek busi compani cover research report result investor
awar firm may conflict interest could affect object report investor consid report singl factor
make invest decis
team alphabet
announc joint ventur verili alphabet life scienc subsidiari build safe environ
facil dayton oh help peopl addict opioid project compani
busi human health took step back acknowledg success give back uniqu
charit fashion doesnt work way rigid wall street process around price target
stock rate think bear mention mani reit way recogn
role play help resolv extrem import issu put deaths/day tie
opioid epidem us compani simpli could sit idli part verili choic
dayton project simpl highest per capita overdos rate unit state
disclos return project like nowher near typic develop compani
estim payback year hope effort imit other help address one
critic need countri today
oper capit market valu consolid pipelin noi wtd average stab capit develop incom capit manag market valu perpetu prefer cost net market valu share op unit asset valu per
 statementful yearful yearful year thousand except per share chgoper incom expensesrent oper invest oper incom unconsolid administr prefer sale sale rental interests/unvest restrict extinguish stock redempt convers prefer unvest restrict stock estat estat nareit factorsexpens acquisit earli extinguish stock redempt convers prefer unvest restrict stock estat earn gain asset charg incom gain sale line rent line rent adjust ground loan debt stock releas fund oper averag averag share opus-dilut averag share opus-dilut period end share amountsffo nareit line rent loan stock releas fund gain extra
